Tilmetamine
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Tilmetamine is a dissociative drug of the arylcyclohexylamine family related to tiletamine.[1][2] It is the analogue of tiletamine in which the N-ethyl group has been replaced with an N-methyl group.[1][2] The drug is said to be 3 to 5 times more potent than ketamine and to have a longer duration.[1][2] It is reported to produce adverse effects, such as blurred vision.[1][2] Tilmetamine is expected to act as an NMDA receptor antagonist similarly to tiletamine and ketamine.[1][2] It was encountered as a novel designer drug online in August 2024.[1][2]
Other namesN-Desethyl-N-methyltiletamine
ATC code
- None
 | |
| Clinical data | |
|---|---|
| Other names | N-Desethyl-N-methyltiletamine |
| Drug class | Dissociative; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C11H15NOS |
| Molar mass | 209.31 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
